What is Viatris's cash & equivalents?

Viatris (VTRS) reported cash & equivalents of $1.81B in Q1 2026.

How has Viatris's cash & equivalents changed year-over-year?

Viatris's cash & equivalents increased by 138.8% year-over-year, from $756.3M to $1.81B.

What is the long-term trend for Viatris's cash & equivalents?

Over 5 years (2020 to 2025), Viatris's cash & equivalents has grown at a 9.7% compound annual growth rate (CAGR), from $850M to $1.35B.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Viatris VTRS Cash & Equivalents

Cash & Equivalents at other companies

PfizerPFE

$1.76B+18.8%

McKessonMCK

$3.98B-33.3%

ANI PharmaceuticalsANIP

$311.21M+108%

CencoraCOR

$2.18B+10.0%

AMP

Amphastar PharmaceuticalsAMPH

$170.94M-6.5%

Aquestive Therapeutics, Inc.AQST

$110.73M+61.3%

Other financials

Income statement

See full

Revenue$3.5B+8.1%

Gross profit$1.2B-0.3%

Operating income-$79.7M+97.2%

Net income$176.4M+106%

EPS (diluted)$0.15+106%

Balance sheet

See full

Total debt$14.6B+1.0%

Total equity$14.7B-6.3%

Total assets$36.8B-4.3%

Cash flow

See full

Operating cash flow$388.3M-27.5%

CapEx$39.9M-6.3%

Free cash flow$348.4M-29.3%

Valuation

See full

Market cap$18.49B+81.7%

Enterprise value$31.3B+29.5%

P/S1.3×+0.5×

Profitability

See full

Gross margin34.4%-2.5pp

Operating margin1%—

Net margin-2%-1.0pp

FCF margin12.3%-1.0pp

Returns & leverage

See full

Return on equity-2%-0.9pp

Debt / equity1×+0.1×

Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viatris's cash & equivalents?: Viatris (VTRS) reported cash & equivalents of $1.81B in Q1 2026.
How has Viatris's cash & equivalents changed year-over-year?: Viatris's cash & equivalents increased by 138.8% year-over-year, from $756.3M to $1.81B.
What is the long-term trend for Viatris's cash & equivalents?: Over 5 years (2020 to 2025), Viatris's cash & equivalents has grown at a 9.7% compound annual growth rate (CAGR), from $850M to $1.35B.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.